Showing results (1811-1820 of 1,952) with videos related to
Sort By:
Pageof 196
Annals of the Rheumatic Diseases|November 1, 2014
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trialP Verschueren, D De Cock, L Corluy, et al.Global Change Biology|November 11, 2018
Global soil nitrous oxide emissions since the preindustrial era estimated by an ensemble of terrestrial biosphere models: Magnitude, attribution, and uncertaintyHanqin Tian, Jia Yang, Rongting Xu, et al.Annals of the Rheumatic Diseases|July 20, 2016
Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trialPatrick Verschueren, Diederik De Cock, Luk Corluy, et al.Swiss Medical Weekly|December 13, 2017
Feasibility, acceptability and effectiveness of integrated care for COPD patients: a mixed methods evaluation of a pilot community-based programmeTania Carron, Pierre-Olivier Bridevaux, Karin Lörvall, et al.Arthritis Research & Therapy|April 19, 2015
Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trialPatrick Verschueren, Diederik De Cock, Luk Corluy, et al.Bjpsych Open|February 3, 2022
Effects of multivitamin, mineral and n-3 polyunsaturated fatty acid supplementation on aggression among long-stay psychiatric in-patients: randomised clinical trialNienke J de Bles, Nathaly Rius-Ottenheim, Johanna M Geleijnse, et al.Lancet (London, England)|July 20, 2015
Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trialEva B Deerenberg, Joris J Harlaar, Ewout W Steyerberg, et al.Arthritis & Rheumatology (Hoboken, N.J.)|September 20, 2020
Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III TrialHermine I Brunner, Nicolino Ruperto, Zbigniew Zuber, et al.The New England Journal of Medicine|December 21, 2012
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritisFabrizio De Benedetti, Hermine I Brunner, Nicolino Ruperto, et al.Annals of Surgery|July 14, 2020
Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03Joerg Heil, André Pfob, Hans-Peter Sinn, et al.Pageof 196